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spermatozoa are eluted from the column. The male

determining spermatozoa are then recovered separately

METHOD FOR X AND Y SPERMATOZOA
SEPARATION

as in the ?rst method.
While the two Bryant methods do serve to increase
the percentage of mammalian offspring of either sex as
desired, the methods are not without their disadvan

This is a continuation of application Ser. No. 818,338,
?led Jan. 10, 1986 now abandoned.

tages and, therefore, may be improved. Speci?cally,
Bryant discloses a complicated technique of animal
immunization with histocompatability (I-I-Y) antigen
and multiple repeated absorptions through female

TECHNICAL FIELD
This invention relates to a method for separating male

and female determining spermatozoa for the purpose of

selectively increasing the probability of producing off

spleen cells to separate and purify the male speci?c
antibody used in the Bryant method. Despite this diffi
cult and tedious technique, it should be appreciated that

spring of either sex.
BACKGROUND OF THE INVENTION
The ability to select the sex of offspring produced in

the resulting antibody is still not completely binding
speci?c to the H-Y antigen found only in male deter
mining and not female determining spermatozoa. Thus,
it should be appreciated that a portion of the resulting
male speci?c antibody used in Bryant could disadvanta

fertilization has long been recognized as having tremen
dous commercial potential and application. An excel
lent example of this may be found in the ?eld of animal

husbandry.
Dairy farm operations require the female of the spe
cies, cows, for milk production. Males of the species,
bulls, are only important for breeding purposes. Thus, it

geously bind through antigens other than the y-antigen
20 to some female determining spermatozoa. As a result,

some female determining spermatozoa are bound to the

is clear that any method that safely and effectively in
creases the production of female offspring versus male

Sephadex beads in the Bryant columns and eluted with
the male determining spermatozoa fraction. Thus, it is
clear that the highest levels of effective separation are

offspring would greatly bene?t dairy cattle breeders

not attainable with the Bryant method.

and farmers and, therefore, be very valuable. Such a
method would allow more effective and ef?cient farm
operation, save money and increase farm milk produc

of a column with antibody/Sephadex bead conjugate.
The column must be packed properly so that the rate of

Bryant also disadvantageously requires the packing

tion.

flow or spermatozoa elution is within a range allowing

Of course, it should be recognized that humans may
also bene?t from such a method of selecting the sex of

complete immunoreaction between the spermatozoa
and the antibody of the antibody/bead conjugates. Too

offspring. Parents could very simply satisfy their desires

fast a ?ow rate means incomplete immunoreaction and

separation and, therefore, the presence of male deter
planning, may reduce family tension and also limit fam
mining spermatozoa in the eluted female determining
35 spermatozoa fraction. The proper packing of the col
ily size for the bene?t of all involved.
Numerous attempts have been made in the past to
umn requires a great deal of preparation time and large
quantities of expensive eluant or ?ltration solution are
separate x-(male determining) and y-(female determin
ing) bearing spermatozoa in order to determine the sex
required to complete the separation and recover the
of the offspring before conception. The methods used
majority of the spermatozoa from the column. This last

to have a son or daughter. This allows improved family

include centrifugation, ?ltration, electrophoresis, im
munological techniques and exposure of spermatozoa to

consideration is particularly important when you con
sider that different eluants are typically required for

alkaline or acidic environments.

each species of spermatozoa being separated. Thus,

large quantities of a number of different and sometimes
Mechanical methods of separating male and female
expensive eluants must be stored at the separation lab.
determining spermatozoa, based on the difference in
An additional problem in Bryant relates to the utiliza
density between the two types, are disadvantageously 45
characterized by reduced spermatozoa survivability
tion of protein containing media for spermatozoa dilu
and by reduced viability of the surviving spermatozoa.
tion prior to exposure of the spermatozoa to the anti
body. Disadvantageously, the protein in the media re
Immunological methods of spermatozoa separation do
tards the cross reactivity of the spermatozoa and the
not suffer as dramatically from these disadvantages.
antibody. It is believed that the existing protein fraction
U.S. pat. no. 4,448,767 to Bryant discloses two meth

ods of immunological spermatozoa separation. The ?rst
method is a single antibody separation system wherein
male speci?c antibody is bound to sephadex beads
placed in a column. Native or unseparated spermatozoa
is then ‘added to the column. The male determining
spermatozoa become bound to the male specific an
tibody/Sephadex bead conjugates as the female sperma
tozoa are eluted from the column. The male determin
ing spermatozoa are then recovered separately.
The second method is a dual antibody separation 60
system wherein native sperm is treated with male spe

ci?c antibody. A second antibody, capable of speci?
cally binding the male speci?c antibody is coupled to

in the spermatozoa diluent coats the spermatozoa cov

ering the histocompatability H-Y antigen sites on the
male determining spermatozoa and preventing an
tibody/antigen binding. This causes incomplete separa
tion as, with either method in Bryant, coated male de
termining spermatozoa are eluted with the female deter

mining spermatozoa.
From the above, it should be appreciated that a need
exists for an improved method of immunologic sperma
tozoa separation.
SUMMARY OF THE INVENTION

It is, accordingly, one object of the present invention
Sephadex beads placed in a column. The male speci?c
to provide a method of spermatozoa separation, based
antibody treated spermatozoa is then added to the col 65 on sex determining properties, overcoming the above
described limitations and disadvantages of the prior art.
umn. The, male determining spermatozoa become
A further object of the present invention is to provide
bound to the second antibody/Sephadex bead conju
an immunological method of spermatozoa separation
gates through the male speci?c antibody as the female
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acted ?rst antibody and resuspended in fresh protein

that is less complicated-and more effective than meth
ods of the prior art.
Still another object of the present invention is to

effectively separate female and male determining sper

free diluent.
Preferably, the second antibody coupled to the aga
rose beads is an anti-immunoglobulin antibody speci?c

matozoa for subsequent fertilization to produce off

for binding with the male-speci?c, ?rst antibody bound

spring of a selected sex with an increased probability of

to the exposed male spermatozoa. The beads are added

to the exposed spermatozoa in the protein free diluent
and the bead/spermatozoa preparation is agitated to
prevent the beads from settling and thereby assure com
mining spermatozoa wherein the separated spermatozoa 0 plete immunoreaction between the two antibodies.
have improved ef?cacy and viability.
Again, the protein free diluent prevents antigen “coat
Other objects and advantages of the present invention
ing” that can adversely effect the cross reactivity of the
will become apparent as the description thereof pro
second antibody with the ?rst antibody and thereby
success.

A still further object of the present invention is to
provide a method of separating male and female deter

ceeds.

reduce separation ef?ciency.

In satisfaction of the foregoing objects and advan
tages, there is provided by this invention a method for
separating male and female determining spermatozoa
for the purpose of selectively increasing the probability
of producing offspring of either sex during subsequent
fertilization.
The method includes the step of exposing unsepa

Following the suspending step, the female determin
ing spermatozoa may be recovered by draining the
bead/spermatozoa preparation solution from the aga
rose beads now bound to the male determining sperma

tozoa. The drained solution is then gently centrifuged
and the undamaged female determining spermatozoa
are recovered in a pellet. The female determining sper
matozoa may then be resuspended in fresh protein free

rated, native spermatozoa to an excess concentration of

a ?rst antibody that binds substantially exclusively with
diluent and ?ltered so as to substantially remove all
male determining spermatozoa through the H-Y surface
dead and weak spermatozoa and increase the ef?cacy of
antigen. A second antibody covalently bound to an 25 the collected fraction. This can done by adding the
immunoabsorbent substrate, such as agarose beads,

spermatozoa to a column of sephadex beads. The viable
spermatozoa are then eluted from the column and col

binds substantially exclusively to the ?rst antibody. The
second antibody/immunoabsorbent conjugates are sus

lected in a protein containing medium for freezing and

pended together with the spermatozoa previously ex
posed to the ?rst antibody in a protein-free diluent ap

/or subsequent use in arti?cial insemination.
The male determining spermatozoa are then recov
ered from the agarose beads. There are many methods
known in the art for such recovery. The methods in

propriate for the spermatozoa being separated. For
example, bovine spermatozoa may be suspended in a
solution of sodium citrate having a pH of approximately
7.2 and an osmotic pressure of approximately 325

clude competitive inhibition using a solution of male

speci?c antibody, enzymatic digestion of the beads and

mOsm. Following immunoreaction in suspension, the 35 alteration of the pH or salt concentration of the diluent.
female determining spermatozoa are recovered while
the male determining spermatozoa are bound to the
immunoabsorbent substrate through the first and sec

The male determining spermatozoa may then be ?l
tered and collected as described above so as to substan

tially remove all dead spermatozoa and increase the

ond antibodies. Lastly, if desired, the male determining

overall ef?cacy of the fraction. Speci?cally, viable sper

spermatozoa are recovered from the substrate.

matozoa pass through the column at a substantially
faster rate than dead spermatozoa and, therefore, excel
lent separation results are attainable.
Still other objects of the present invention will be
come readily apparent to those skilled in this art from

More speci?cally, the native spermatozoa are diluted
in a protein-free diluent to a concentration of between

10X 106 to lOOX 106 active spermatozoa per milliliter

depending on the species being separated. Since the

diluent is protein free, there is no coating of the surface 45 the following description wherein there is shown and
of the spermatozoa and, more particularly, the H-Y
described a preferred embodiment of this invention,
antigen sites on the male determining spermatozoa.
simply by way of illustration of one of the modes best
Thus, more effective and complete immunoreaction is
suited to carry out the invention. As it will be realized,
assured between the ?rst antibody and the male deter
the invention is capable of other different embodiments
mining spermatozoa.
50 and, its several details are capable of modi?cations in
Preferably, the ?rst antibody is a male speci?c mono
various, obvious aspects all without departing from the

clonal antibody directed against H-Y antigen on the
male determining spermatozoa. These monoclonal anti
bodies, available from the National Institute of Health,

are prepared by outgrowth of primary hybridomas and
recovery of the cultured medium. By using monoclonal
antibodies of this type, no other antibodies are present in
the antisera to adversely effect or block the cross reac

tivity of the antibodies with the I-I-Y antigen on the
male determining spermatozoa or to bind any other
antigen such as may be found on the female determining

spermatozoa. Optimum selective binding is therefore
assured.

Following the exposing step, the exposed spermato
zoa are separated from the excess concentration of the

?rst antibody. This separation may be performed by

invention. Accordingly, the drawings and descriptions
will be regarded as illustrative in nature and not as

restrictive.
55

BRIEF DESCRIPTION OF THE DRAWING

The accompanying drawing incorporated in and
forming a part of the specification, illustrates several
aspects of the present invention, and together with the
description serves to explain the principles of the inven
tion. In the drawing:

.

FIG. 1 is a flow sheet illustrating the method of the

present invention;
FIG. 2 is a schematical representation showing the

monoclonal antibody directed against I-I-Y antigen
binding with the male determining spermatozoa; and

gentle centrifugation that does not harm the spermato

FIG. 3 is a schematical representation showing the

zoa. The spermatozoa are then washed to remove unre

binding of the second antibody/bead conjugates to the

5
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exposed and monoclonal I-I-Y antibody bound male

6

zoa are exposed to monoclonal H-Y antibody produced
by mice lymphocyte cells as described above, the sec
ond antibody bound to the conjugate must be anti
mouse immunoglobulin G. Such a conjugate of anti
mouse immunoglobulin G and agarose beads is available

determining spermatozoa.
DETAILED DESCRIPTION OF THE
INVENTION

As shown in FIG. 1, the ?rst step 12 of the method 10

from Sigma Corporation.

'

of the present invention involves exposing live, native

The anti-immunoglobulin G/agarose bead conjugate

spermatozoa to an excess concentration of an antibody

is added to the diluted spermatozoa at an approximate
concentration of 0.4 milliliters of conjugate beads per
milliliter of diluted spermatozoa (assuming a minimum
of 0.4 milligrams of mouse immunoglobulin G may be
bound and eluted from each milliliter of antibody

that binds substantially exclusively to male determining

spermatozoa. Speci?cally, freshly ejaculated spermato
zoa are diluted to a concentration of between 10X 106

and lOOX 106 active spermatozoa per milliliter. The
diluent used varies depending on the species of the

bound beads). The conjugate/spermatozoa preparation

spermatozoa being separated. Speci?c examples of dilu

is incubated at approximately 37° C. and agitated to
prevent the beads from settling and thereby maintain

ents include sodium citrate solution for bovine sperma
tozoa, creme gel buffer for equine spermatozoa and test

the beads and spermatozoa in physical contact for com—

buffer for human spermatozoa. The diluent used, how
ever, should be free of protein as any protein in the

plete immunoreaction. During this time, the anti
immunoglobulin G antibody of the conjugate binds the

diluent tends to coat the spermatozoa and block the

monoclonal H-Y antibody bound to the male determin‘
ing spermatozoa as shown in FIG. 3. Thus, the an“

H-Y antigen binding sites on the surface of the male

determining spermatozoa. Thus, by substantially elimi

tibody/bead conjugate agglutinates the monoclonal

nating this blocking the method of the present invention
provides conditions for optimal cross reactivity be
tween the antibody and antigen for the best possible

antibody/male determining spermatozoa complexes.

immunoseparation results.

Following immunoreaction and agglutination, the ‘

female determining spermatozoa are recovered at step
25 30. This step may be completed by draining the con

An excess concentration of the male speci?c antibody

jugate/spermatozoa preparation solution from the an
tibody/agarose bead conjugates now bound to the male
determining spermatozoa. Since the female determining
spermatozoa do not bind to the beads (note FIG. 3), the
female determining spermatozoa are contained in this
drained solution. The solution is then gently centrifuged
to collect the female determining spermatozoa in a pel
let at the bottom of the centrifuge tube without signi?

is contained in or added to the diluent and spermatozoa.
' The male speci?c antibody is a monoclonal anti-H-Y

antibody (immunoglobulin G) prepared by outgrowth
of primary hybridomas and recovered from culture
medium by stepwise precipitation and dialysis. Such a
monoclonal antibody is produced by the mouse lym
phocyte hybrid cell line B6YD1O available from the
National Institute of Health.
As shown in FIG. 2, only male determining sperma

cantly adversely affecting spermatozoa viability.
35

tozoa 14 express the H-Y antigen 16 on their surface.
The female determining spermatozoa 18 do not express
the I-I-Y antigen believed associated with the Y or male
determining chromosome. Since the monoclonal anti

matozoa are then resuspended in a diluent and added in

step 32 to the ?ltering column. Viable spermatozoa pass
through or are eluted from the column at a substantially
faster rate than dead or weak spermatozoa and, there
fore, excellent ?ltering results are obtainable. The sper
matozoa eluted from the column may be collected in a

body 20 is absolutely speci?c for the I-I-Y antigen, it
binds only to the male determining spermatozoa 14 and
not any of the female determining spermatozoa 18.
Following a short incubation period for immunoreac

tion of, for example, 45 minutes, the spermatozoa/
monoclonal H-Y antibody dilution is centrifuged in step
22 to remove (note FIG. 1)'and collect the exposed

spermatozoa from the diluent. The exposed spermato
zoa are then washed (also step 22) using fresh, pure
protein free diluent in order to‘ remove unbound mono

clonal antibody. After washing, the exposed spermato
zoa are resuspended in an equal volume of protein free

A Sephadex ?ltering column is then prepared as is
known in the art. The pelleted female determining sper

protein containing medium for maintaining the sperma
45

tozoa for freezing and/or subsequent use in arti?cial
insemination. An example of such a protein containing
medium is the protein free diluent used above during
the exposing and suspending steps mixed with egg yolk,
20% by volume.
The male determining spermatozoa are also recov

50 ered at step 34 from the agarose beads. There are many

diluent (as used during the exposing step) substantially

methods known in the art for such recovery. The meth
ods include competitive inhibition using a solution of

without the presence of unbound H-Y antibody.

male speci?c antibody, enzymatic digestion of the

Immediately thereafter, antibody/immunoabsorbent

beads, and alteration of the pH or salt concentration of

conjugates are added to the dilution so as to form a 55 the diluent. Following recovery, the male determining

conjugate/spermatozoa suspension preparation in step

spermatozoa are ?ltered in step 36 through a Sephadex

24. As shown in FIG. 3, the antibody 26 coupled to the
immunoabsorbent material or agarose beads 28 binds

column in the same manner as the female determining
spermatozoa so as to increase the efficacy of the male

immunoglobulin G and, therefore, binds the mono
clonal anti-H-Y antibody 20 already bound to the male

determining spermatozoa fraction or sample.
The following examples are presented to further illus

determining spermatozoa 14. Again, just as with the
first antibody 20, the female determining spermatozoa

trate the invention, but it is not to be considered as
limited thereto.

18 do not immunoreact with the immunoglobulin G
antibody 26 bound to the beads 28.

EXAMPLE 1

In order for the second, immunoglobulin G antibody 65 HY antibody is obtained by outgrowth of a mono
26, to properly react with the monoclonal I-I-Y antibody
clonal hybridoma cell culture (American Type Culture
20, the immunoglobulin G antibody must be species
Collection, Number, B6YD10). The cell culture is
speci?c for the monoclonal antibody. Thus, if spermato
grown in RPMI 1640 medium with L-Glutamine (M.A.

7
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Bioproducts) containing 200 Units of Gentomycin per
ml and supplemented with 20% fetal bovine serum. The

growth environment is an incubator gassed via 5% CO2
in air and maintained at 37“ C. Supernatant is harvested
at 48-hour intervals and frozen at —-20° C. environment

until processing. The antibody (globulin fraction) is
collected from the supernatant by precipitation with

8

Flow rates are adjusted to approximately 0.5-0.7 ml
per minute measured by the 2.5-1.5 ml markings on the
syringe-?lters. Fast flow rates indicate insuf?cient ?ber

glass or holes in the ?berglass pads which would allow
Sephadex to pass into the collection vials. Slow flow
rates, however, are caused by too much ?berglass in the
pad and may result in insuf?cient ?ltering. The ?lters

are allowed to drain to the 1 ml mark and then the ?lter
50% saturated ammonium sulfate (3 X). The ammonium
is re?lled with the diluent from a wash bottle, taking
sulfate is then removed via dialysis against sodium ci
trate diluent (SCD). During this process, globulin frac 0 care not to disturb the Sephadex surface. The ?lters are
tions are concentrated into a volume which is one tenth

of the original culture fluid collected. The recovered
globulin fractions are aliquoted into 1 ml fractions, fro
zen, and maintained at —-70° C. environment until use.

EXAMPLE 2

Bovine spermatozoa are collected by any appropriate
method known in the art. The semen is collected di

allowed to drain to the 2.5 ml level and the beaker is
replaced with a 20 ml volumetric ?ask and a 1 ml semen

sample containing 40X 106 active spermatozoa is added
or layered to the top of the column. All samples are
mixed immediately before sampling to assure accuracy.
Adequate time is allowed for the ?lter to drain to 1.2 ml
mark and then to be re?lled to the top with additional
sodium citrate solution.
Male determining spermatozoa are recovered as fol

rectly into a prewarmed vessel at 37° C. and maintained
at this temperature until dilution 10 to 15 minutes later. 20 lows. Agarose beads recovered following draining of
The freshly ejaculated bovine spermatozoa are diluted
the female determining spermatozoa are mixed with

to 40><106 active spermatozoa per ml by adding an

appropriate quantity of physiologically balanced so
dium citrate solution at 325 m Osm/liter, pH 7.2, and
free of protein. An excess concentration of 1:200 mono 25

monoclonal H-Y antibody twice the original concentra
tion used during the female determining spermatozoa
separation procedure. As it may be noted, the agarose
heads at the end of the separation procedure formed
complexes made out of the antibody/bead conjugate
which agglutinated the monoclonal antibody/ male de
termining spermatozoa. The added H-Y antibody in
excess (2X the original concentration) is mixed gently
via agitation to break the bondage of the male spermato

clonal antibody directed against HY antigen as pre
pared in Example 1 is then added to the diluted sperma
tozoa. The spermatozoa preparation is then incubated
for a period of 45 minutes at 37° C. The preparation is
then centrifuged for 10 minutes at 1,000 g and the sper
matozoa collected in a pellet. The spermatozoa pellet is
zoa and the agarose bead. As the bondage is broken, the
then resuspended in an equal volume of sodium citrate
H-Y antibody then cross reacts with the anti-immuno
solution without the HY antibody. Immediately thereaf
globulin G site on the agarose bead rendering it inactive
ter, 0.4 ml of agarose beads covalently bound with anti
(inhibited). The method via which the process of sepa
mouse IgG (available from Sigma Chemical Company, 35 ration of the male determining spermatozoa form the
bead conjugates is otherwise known as competitive
St. Louis, Mo.) are added per ml of diluted spermato
zoa. This spermatozoa-agarose bead suspension is then
inhibition. The agitation for purposes of separation of
incubated for 30 minutes at 37“ C. Since the beads settle
the male spermatozoa may continue for 30 minutes (at
to the bottom of the suspension if allowed to set for ?ve

minutes or longer, the suspension is agitated or mixed
every 10 minutes to keep the sperm and beads in physi

37° C.) or until no visible physical bondage between the
beads and the spermatozoa is evident. Following this.

period, the sperm fraction is collected by decanting or

the agitated solution is allowed to sit for an additional
30 minutes to allow the beads to settle to the bottom of
the container and then the supernatant is removed

draining the supernatant. Following collection, the

which would contain the freed male spermatozoa (37°

cal contact. At the end of the 30 minute incubation

sperm fraction is transferred and layered on top of a 45 C.). Following recovery the male determining sperma
Sephadex sperm'?ltration column and ?ltered.
tozoa are ?ltered in step 36 through a Sephadex column

Actually, the column consists of three disposable
plastic syringes each 1 cm in diameter and 6.5 cm high.
A pad of Johns-Manville Micro-Fiber, code 112, No.
475 glass, is prepared by taking thin sheets of 3 to 4 mg
?ber and folding the long ?bers under to make a circle
of approximately 1 cm in diameter. A pad is then gently
pushed to the bottom of each syringe using a Pasteur
pipet until l to 2 mm protrudes through the hole in the
syringe. The ?bers are inspected so that no holes should 55

be evident in the syringe. Twenty g of Sephadex G 15
(40-120 particle size) are added to 100 ml of diluent, 34
g/liter, 320 mOsm osmotic pressure. The sephadex is

in the same manner as the female determining spermato
zoa and processed either for arti?cial insemination or

for cryopreservation purposes.
We claim:
1. The method for separating male and female deter

mining spermatozoa for the purpose of controlling the
sex of offspring prior to conception, comprising the
steps of:
exposing the spermatozoa in a protein free diluent to
an excess concentration of a ?rst antibody that

binds male determining spermatozoa;
, suspending said exposed spermatozoa together with a

then allowed to swell at 5° C. for 4 hours. Each syringe
is ?lled with sodium citrate solution to the 2.5 ml level. 60

conjugate of a second antibody that binds exclu
sively to said ?rst antibody and an immunoabsorb

A volume of 0.8 ml of rapidly mixing Sephadex slurry is
then added to the diluent in each syringe. The Sephadex

ent substrate in a protein free diluent to form a

is allowed to settle for 10 minutes and then the ?lter is
ready for use. The Sephadex column should be set at 8

recovering the female determining spermatozoa from
the conjugate/spermatozoa preparation while said

mm height. More Sephadex may be added, if necessary, 65

male determining spermatozoa are bound to said
immunoabsorbent substrate.
2. The method for separating male and female deter

until the level reaches the 8 mm mark. The ?lters are
?rmly held in a vertical position and a beaker is used to

catch the ?ltrate.

conjugate/spermatozoa preparation; and

mining spermatozoa recited in claim 1, including the

4,999,283
additional step of recovering said male determining

10

said conjugate/spermatozoa preparation to prevent the
immunoabsorbent substrate from settling.

spermatozoa from said immunoabsorbent substrate.
3. The method for separating male and female deter
mining spermatozoa recited in claim 1, wherein said

12. The method for separating male and female deter
mining spermatozoa recited in claim 1, wherein said

exposing step includes the additional step of diluting

female determining spermatozoa recovering step in

said spermatozoa to a concentration of between

cludes the steps of draining said protein free diluent and
female determining spermatozoa from said immunoab
sorbent substrate and then centrifuging said protein free
diluent and female determining spermatozoa to separate
said female determining spermatozoa from said diluent.
13. The method for separating male and female deter
mining spermatozoa recited in claim 1, including the
additional step of ?ltering the separated female deter

10X 106 and lOOX 106 active spermatozoa per milliliter
of protein free diluent.
4. The method for separating male and female deter
mining spermatozoa recited in claim 1, wherein said
?rst antibody is monoclonal antibody directed against

H-Y antigen of said male determining spermatozoa.
5. The method for separating male and female deter

mining spermatozoa recited in claim 1, including the
steps of recovering said exposed spermatozoa from said

mining spermatozoa so as to substantially remove dead

spermatozoa and increase overall ef?cacy.

excess concentration of said ?rst antibody and washing
said exposed spermatozoa to remove unbound ?rst anti

body.

14. The method for separating male and female deter
mining spermatozoa recited in claim 13, wherein said

recovering is by centrifugation.

sephadex bead column.

?ltering step includes the step of passing the separated
6. The method for separating male and female deter
mining spermatozoa recited in claim 5, wherein said 20 female determining spermatozoa through an unbound
15. The method for separating male and female deter
mining spermatozoa recited in claim 2, including the
additional step of ?ltering the separated male determin

7. The method for separating male and female deter

mining spermatozoa recited in claim 5, including the
step of resuspending said washed, exposed spermatozoa

in a protein free diluent.
25 ing spermatozoa so as to substantially remove dead
spermatozoa and increase overall ef?cacy.
8. The method for separating male and female deter

additional step of incubating said spermatozoa at ap

16. The method for separating male and female sper~
matozoa recited in claim 2, including the additional

proximately 37“ C. during said exposing and suspending
steps.

male determining spermatozoa so as to remove dead

mining spermatozoa recited in claim 1, including the

steps of separately ?ltering the separated male and fe
spermatozoa and increase overall ef?cacy and sepa

9. The method for separating male and female deter
mining spermatozoa recited in claim 1, wherein said

rately collecting said separated male and female deter
mining spermatozoa in a protein containing media fol

immunoabsorbent substrate is agarose beads.

lowing ?ltering, said protein containing media serving
10. The method for separating male and female deter
mining spermatozoa recited in claim 1, wherein said 35 to support the separated spermatozoa until subsequent
second antibody is anti‘immunoglobulin antibody capa

use in arti?cial insemination.

ble of binding said ?rst antibody.

17. The method for separating male and female deter
mining spermatozoa recited in claim 1, wherein said
protein free diluent is a sodium citrate buffer.

11. The method for separating male and female deter
mining spermatozoa recited in claim 1, wherein said
suspending step includes the additional step of agitating

it
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